Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Pfizer (NY:PFE)

25.07 -0.14 (-0.54%)
Streaming Delayed Price Updated: 12:28 PM EDT, Jun 22, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Pfizer

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
Pfizer Stock Edges Lower Monday: What's Going On? ↗
Pfizer shares are trading lower by about half a percent on Monday as investors digest a leadership transition in the finance seat. 
Via Benzinga
News headline image
GEA Group Aktiengesellschaft Targets EUR 7B Revenue, Higher Margins by 2030 ↗
GEA Group Aktiengesellschaft (ETR:G1A) outlined its 2030 growth and profitability targets during an Industrial Technology Conference presentation, with Investor Relations Manager Eduard Biller saying... 
Via MarketBeat
Topics Supply Chain
News headline image
Pfizer Isn't Expecting to Make Any Big Acquisition in the Next Couple of Years, but It's Planning to Do This Instead ↗
The healthcare company is eyeing opportunities related to artificial intelligence, which it believes can enhance its operations. 
Via The Motley Fool
Topics Artificial Intelligence Earnings Intellectual Property
News headline image
GLP-1 Receptor Agonist Market Revenue Analysis Across Key Regions ↗
The global GLP-1 Receptor Agonist Market was valued at USD 66.4 billion in 2025 and is projected to grow from USD 82.0 billion in 2026 to USD 185.3 billion 
Via Talk Markets
News headline image
2 Reasons to Like ZTS and 1 to Stay Skeptical
Zoetis has gotten torched over the last six months - since December 2025, its stock price has dropped 36.6% to $78.46 per share. This was partly driven by it... 
Via StockStory
News headline image
Could Pfizer Stock Be Your Ticket to Generational Wealth? ↗
Pfizer is struggling right now, leaving it in the Wall Street doghouse; it won't be there forever. 
Via The Motley Fool
Topics Intellectual Property
News headline image
Want to Retire on $500,000? 3 Stocks to Buy and Never Sell ↗
These dividend stocks could help make retiring on $500,000 a real possibility. 
Via The Motley Fool
Topics Artificial Intelligence Retirement
News headline image
Pfizer's Dividend Yield is 10X Bigger Than Eli Lilly's. Does That Make It the Better Stock for Income Investors? ↗
Pfizer is out of favor right now, and for good reason, but dividend investors may want to take the risk just the same. 
Via The Motley Fool
Topics Intellectual Property
Apple's Price Warning Sends Memory Chips To A Record, Accenture Cracks 18% ↗
Via Chartmill
News headline image
Stock Market Today, June 18: Pfizer Falls as CFO Transition Tests Confidence in 2026 Outlook ↗
Pfizer’s recent drug approvals give the company something to build on, with shareholders looking for evidence that cost cuts and newer medicines can keep the 2026 earnings outlook on track. 
Via The Motley Fool
Topics Intellectual Property Stocks
Thursday's session: most active stock in the S&P500 index ↗
Via Chartmill
These S&P500 stocks have an unusual volume in today's session ↗
Via Chartmill
News headline image
Pfizer Stock Drops Today As CFO Steps Down In August ↗
Pfizer shares are slipping Thursday after it announced that Chief Financial Officer Dave Denton will leave the organization. 
Via Benzinga
News headline image
Pfizer Announces Chief Financial Officer Transition
From Pfizer Inc.
Via Business Wire
News headline image
Consumer Watchdog Honors Michael A. Kelly with 2026 Lifetime Legal Achievement Award
June 17, 2026 -- The award recognizes distinguished attorneys and public-interest advocates whose careers have advanced consumer protection, challenged corporate misconduct, and improved public... 
Via 24-7 Press Release
News headline image
3 S&P 500 Stocks Worth Your Attention
The S&P 500 (^GSPC) is packed with companies that have built dominant market positions, making it a core index for investors. A select few continue to innova... 
Via StockStory
Topics Stocks
News headline image
How to Build a Retirement Income Plan That Lasts Through a High-Inflation Decade ↗
If you haven't planned for inflation, and possibly high inflation, your nest egg's purchasing power could shrink alarmingly. 
Via The Motley Fool
Topics Bonds ETFs Economy
News headline image
1 Cash-Producing Stock with Exciting Potential and 2 Facing Headwinds
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. Luc... 
Via StockStory
News headline image
A Look Back at Therapeutics Stocks’ Q1 Earnings: Novavax (NASDAQ:NVAX) Vs The Rest Of The Pack
As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the therapeutics industry, including Novav... 
Via StockStory
Topics Artificial Intelligence
News headline image
Here's When Pfizer's CEO Says the Company Might Get Back to Generating High-Single-Digit Growth ↗
Pfizer's business may be in better shape than investors think. 
Via The Motley Fool
Topics Earnings Intellectual Property
News headline image
How Safe is Bristol Myers Squibb's Dividend? Here's My Honest Take. ↗
Bristol Myers Squibb has a well-above-market yield of 4.5% and it appears reasonably safe. 
Via The Motley Fool
Topics Bonds Intellectual Property
News headline image
Have S&P 500 Index Funds, Often Touted as the Best Stock Investments, Become Dangerous? There's a Worrisome Development -- and a Possibly Better Alternative. ↗
The hard-earned dollars you park in a standard S&P 500 index fund may not be distributed the way you think they are. 
Via The Motley Fool
Topics ETFs Stocks
News headline image
Pfizer's New Weight-Loss Data Just Gave Eli Lilly and Novo Nordisk Investors Something to Worry About ↗
The pharmaceutical company's flagship anti-obesity drug continues to bolster its efficacy and tolerability arguments. 
Via The Motley Fool
Thursday's session: most active stock in the S&P500 index ↗
Via Chartmill
News headline image
Patent Cliff Predators: GSK Acquires Nuvalent For $10.6 Billion ↗
GSK agreed to acquire Nuvalent for $10.6 billion, or $124 per share, a roughly 40% premium, to add two late-stage lung cancer assets and offset an impending patent cliff. 
Via MarketBeat
Topics Intellectual Property
News headline image
Why Pfizer Stock Popped Today ↗
Pfizer stock may not be cheap enough to buy yet, but it's certainly too cheap to sell. 
Via The Motley Fool
News headline image
Lexicon Pharmaceuticals vs. Pfizer: Which Drugmaker Stock Is a Better Buy in 2026? ↗
One company posts rapid revenue growth but remains unprofitable, while the other boasts global scale and steady cash flow. See how their fundamentals stack up. 
Via The Motley Fool
News headline image
Amneal Pharmaceuticals Bets on Biosimilars, Patches to Power Next Growth Phase ↗
Amneal Pharmaceuticals (NASDAQ:AMRX) Co-Founder, President and Co-Chief Executive Officer Chirag Patel said the company is entering a stronger growth phase, driven by momentum in its existing generics... 
Via MarketBeat
News headline image
Caribou Biosciences Says CRISPR CAR-T Is Pivotal-Ready, CB-011 Data Nears ↗
Caribou Biosciences (NASDAQ:CRBU) Chief Executive Officer Rachel Haurwitz said the company is advancing two CRISPR-enabled, off-the-shelf CAR T cell therapy programs, with its lymphoma candidate... 
Via MarketBeat
News headline image
2 of Wall Street’s Favorite Stocks on Our Watchlist and 1 We Brush Off
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these f... 
Via StockStory
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.